Kenvue (KVUE) FY2024 10-K Annual Report
Kenvue (KVUE) 10-K annual report for fiscal year 2024, filed with SEC EDGAR on Feb 24, 2025. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.
Kenvue FY2024 10-K Analysis
Management Discussion & Analysis
- • Operating cash flow $1.8B down $1.4B YoY from $3.2B in fiscal 2023, decline driven by working capital changes
- • Financing cash outflow $1.6B in fiscal 2024, included $1.55B dividends and $235M share repurchases; repurchased 10.86M shares for $235M
Risk Factors
- • Talc-related litigation risk for Johnson’s® Baby Powder sold outside US/Canada, with talc-based powder discontinued globally in 2023
- • Global operations exposed to foreign currency fluctuations and geopolitical conflicts impacting supply and costs
Kenvue FY2024 Key Financial MetricsXBRL
Revenue
$15.5B
▲ +0.1% YoY
Net Income
$1.0B
▼ -38.1% YoY
Gross Margin
58.0%
▲ +200bp YoY
Operating Margin
11.9%
▼ -435bp YoY
Net Margin
6.7%
▼ -411bp YoY
ROE
10.7%
▼ -419bp YoY
Total Assets
$25.6B
▼ -8.1% YoY
EPS (Diluted)
$0.54
▼ -40.0% YoY
Operating Cash Flow
$1.8B
▼ -44.2% YoY
Source: XBRL data from Kenvue FY2024 10-K filing on SEC EDGAR. All figures in USD.
Other Kenvue Annual Reports
Get deeper insights on Kenvue
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.